Sd. Fox et al., ENHANCED RESPONSE TO OZONE EXPOSURE DURING THE FOLLICULAR PHASE OF THE MENSTRUAL-CYCLE, Environmental health perspectives, 101(3), 1993, pp. 242-244
Exposure to ozone (03), a toxic component of photochemical smog, resul
ts in significant airway inflammation, respiratory discomfort, and pul
monary function impairment. These effects can be reduced via pretreatm
ent with anti-inflammatory agents. Progesterone, a gonadal steroid, is
known to reduce general inflammation in the uterine endometrium. Howe
ver, it is not known whether fluctuations in blood levels of progester
one, which are experienced during the normal female menstrual cycle, c
ould alter 03 inflammatory-induced pulmonary responses. In this study,
we tested the hypothesis that young, adult females are more responsiv
e to O3 inhalation with respect to pulmonary function impairment durin
g their follicular (F) menstrual phase when progesterone levels are lo
west than during their mid-luteal (ML) phase when progesterone levels
are highest. Nine subjects with normal ovarian function were exposed i
n random order for 1 hr each to filtered air and to 0.30 ppm O3 in the
ir F and ML menstrual phases. Ozone responsiveness was measured by per
cent change in pulmonary function from pre- to postexposure. Significa
nt gas concentration effects (filtered air versus 03) were observed fo
r forced vital capacity (FVC), forced expiratory volume in 1 sec (FEV1
), and forced expiratory flow between 25 and 75% of FVC (FEF25-75; p<.
05). More importantly, the pulmonary function flow rates, FEV1 and FEF
25-75, showed a significant menstrual phase and gas concentration inte
raction effect, with larger decrements observed in the F menstrual pha
se when progesterone concentrations were significantly lower. We concl
ude that young, adult females appear to be more responsive to acute O3
exposure during the F phase than during the ML phase of their menstru
al cycles. This difference in pulmonary function response could be rel
ated to the anti-inflammatory effects of increased progesterone concen
trations during the luteal phase.